Daniel Pollyea, MD, elaborates on the evolving treatment landscape in myelodysplastic syndromes

2 Views
administrator
administrator
07/04/23

Dr. Pollyea, Associate Professor/Clinical Director of Leukemia Services, Division of Hematology, University of Colorado School of Medicine, elaborates on how the treatment of myelodysplastic syndromes is changing as a result of clinical data presented at ASH 2019

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next